Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Hargreaves Lansdown Hit After Profit Drop

Wed, 04th Feb 2015 11:40

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
Sky, up 1.9%. The company posted a big increase in pretax profit for the first half of its financial year, boosted by a rise in revenue and exceptional gains from the sale of its stakes in ITV PLC and the National Geographic Channel. Profit was boosted by a GBP492 million gain from the sale of its 6.4% stake in ITV PLC and a GBP296 million gain from the sale of its stake in the National Geographic Channel.

Arm Holdings, up 1.6%. The chip designer announced a new suite of intellectual properties that are expected to be launched on mobile devices in 2016, including its ARM Cortex-A72 processor. The group said that in target configurations, the new processor well deliver CPU performance that is 50 times that of leading smartphones from five years ago.

Antofagasta, up 1%, Rio Tinto, up 0.4%, Glencore, up 0.4%, Fresnillo, up 1.3%, and Randgold Resources, up 0.5%, Mining shares are up after China's central bank lowered its banks' reserve requirement ratio by 0.5 percentage points in order to support lending. The gold miners are  getting a boost from a rise in the gold price to USD1,268.86.

GlaxoSmithKline, up 0.3%. Sky News reported that it has learnt that Glaxo has hired Citi, Goldman Sachs and Morgan Stanley as financial advisers on its HIV medicines joint venture ViiV Healthcare. It says the appointment of the banks will fuel the prospect of Glaxo floating the division, which analysts believe could be worth at least GBP17 billion. The shares are up ahead of the company's full year results at 1200 GMT.
-------
FTSE 100 LOSERS
-------
Hargreaves Lansdown, down 5.7%. The investment management product provider reported a drop in first-half pretax profit, despite a rise in assets under administration over the course of the six months, in what was described as a "muted" time for stocks and retail investors. The group said pretax profit declined to GBP101.9 million in the six months ended December 31 from GBP104.1 million in the corresponding period last year.

Tullow Oil, down 3.9%, BP, down 1.5% and Weir Group, down 1.4%. A drop in oil prices is dragging down oil-related stocks. Brent currently trades at USD56.44 a barrel. Moreover, Royal Dutch Shell B, down 1.9%, and Royal Shell A, down 1.5%, has suffered price target cuts. Liberum has cut the oil major price target to 2,120p from 2,230p, keeping its rating at Hold, while LBBW has cut the company's price target price target to 2,450p from 2,600p, keeping its rating at Buy.
-------
FTSE 250 WINNERS
-------
BTG, up 1.4%. Panmure has raised the Healthcare company's price target to 1,305p from 800p, keeping its rating at Buy.
-------
FTSE 250 LOSERS
-------
Afren, down 7.5% and Premier Oil, down 2.5%. Both oil-related stocks are suffering from the fall in oil prices.

Moneysupermarket.com Group, down 3.9%. Numis said the stock is overvalued against its online listed peers, based on numerous metrics, and the broker would be downbeat on the company at its current share price even without the potential threat posed by Google
-------
AIM ALL-SHARE WINNERS
-------
Camkids Group, up 38%. The China-based children's clothing company shares are up, even though it said it expects its results for the year to miss market expectations after a number of orders were cancelled in December, exacerbating existing problems the company was facing from the weaker economic environment in China. Following that warning, certain distributors for Camkids requested the postponement or cancellation of some orders totalling CNY79 million. The company said it thought its shares were being undervalued.

Dillistone Group, up 19%. Recruitment software supplier said it expects its full year results for 2014, excluding acquisition related items, will be at a similar level to 2013, and said it enters 2015 with a stronger pipeline. The company said order intake in its Systems Division rose more than 20% in the fourth quarter of 2014. It said it had won more new business contracts in December than it had in any month of the last two years.

Nostra Terra Oil and Gas Co, up 8.7%. The company said it placed four new wells into production during the fourth quarter which significantly increased production and said although its partners are cutting back on drilling activity, it will take advantage of the low oil price to try and secure further growth opportunities.

Mosman Oil and Gas, up 6.9%. The group said it has started flow testing on the Crossroads-1 well at its Petroleum Creek project in New Zealand and it has now received the technical report on the cores and cuttings from the 2014 drilling programme at Crestal-1 and Crestal-2.
-------
AIM ALL-SHARE LOSERS
-------
Craven House Capital, off 8%. Investment company said that talks over a potential investment have ended, after it had confirmed last month that talks were ongoing. "The company confirms that these discussions have been terminated," Craven House Capital said.
-------

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.